News

News search

Latest news

New studies aim to improve survival for patients with HER2+ breast cancer
November 27, 2019

Roughly 20 percent of breast cancers test positive for HER2, a protein known to promote cancer growth. HER2-positive (HER2+) tumors can spread more quickly and are less sensitive to hormone therapy than other types of breast cancer. Therapies that target the HER2 protein can be effective, particularly in early-stage disease, yet effective treatments for advanced and metastatic HER2+ breast cancer are needed.

Elsie Franz Finley: Agent of Change, Friend of Providence
November 01, 2019

The best measure of the generosity of Elsie Franz Finley is not a dollar figure, but rather by the hope her lifetime of philanthropy has given to so many in the community and across the Northwest.

In recognition of her decades of support, totaling more than $62 million, Providence Portland Medical Center has named the radiation oncology department in her honor: The Elsie Franz Finley Radiation Oncology Center. 

New probody immuno-oncology study for solid tumors
October 30, 2019

Probody therapeutics are an emerging class of immuno-oncology therapies aimed at reducing the...